Structure-activity relations of myxinidin, an antibacterial peptide derived from the epidermal mucus of hagfish

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 11, 2013, Pages 5665-5673

  Cantisani, Marco ^a,b,c   Leone, Marilisa ^b   Mignogna, Eleonora ^a   Kampanaraki, Katerina ^a   Falanga, Annarita ^a,b   Morelli, Giancarlo ^a,b   Galdiero, Massimiliano ^a   Galdiero, Stefania ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; MYXINIDIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; EPIDERMIS; GRAM POSITIVE BACTERIUM; HAGFISH; HEMOLYSIS; MUCUS; MYXINE GLUTINOSA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; EPIDERMIS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HAGFISHES; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUCUS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, SECONDARY; STATIC ELECTRICITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84885897528     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01341-13     Document Type: Article

References (51)

1. Livermore DM. 2009. Has the era of untreatable infections arrived? J. Antimicrob. Chemother. 64(Suppl 1):i29 -i36. doi:10.1093/jac/dkp255.
2. Hawkey PM. 2008. The growing burden of antimicrobial resistance. J. Antimicrob. Chemother. 62(Suppl 1):i1-i9. doi:10.1093/jac/dkn241.
3. Choi KY, Chow LN, Mookherjee N. 2012. Cationic host defence peptides: multifaceted role in immune modulation and inflammation. J. Innate Immun. 4:361-370.
4. Bowdish DM, Davidson DJ, Hancock RE. 2005. A re-evaluation of the role of host defence peptides in mammalian immunity. Curr. Protein Pept. Sci. 6:35-51.
5. Jenssen H, Hamill P, Hancock RE. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19:491-511.
6. Wiesner J, Vilcinskas A. 2010. Antimicrobial peptides: the ancient arm of the human immune system. Virulence 1:440-464.
7. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.
8. Easton DM, Nijnik A, Mayer ML, Hancock RE. 2009. Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol. 27:582-590.
9. Perron GG, Zasloff M, Bell G. 2006. Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci. 273:251-256.
10. Radzishevsky IS, Rotem S, Bourdetsky D, Navon-Venezia S, Carmeli Y, Mor A. 2007. Improved antimicrobial peptides based on acyl-lysine oligomers. Nat. Biotechnol. 25:657-659.
11. Rotem S, Mor A. 2009. Antimicrobial peptide mimics for improved therapeutic properties. Biochim. Biophys. Acta 1788:1582-1592.
12. Gordon YJ, Romanowski EG, McDermott AM. 2005. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr. Eye Res. 30:505-515.
13. Yedery RD, Reddy KV. 2005. Antimicrobial peptides as microbicidal contraceptives: prophecies for prophylactics-a mini review. Eur. J. Contracept. Reprod. Health Care 10:32-42.
14. Kim YC, Ludovice PJ, Prausnitz MR. 2010. Transdermal delivery enhanced by antimicrobial peptides. J. Biomed. Nanotechnol. 6:612-620.
15. Clara A, Manjramkar DD, Reddy VK. 2004. Preclinical evaluation of magainin-A as a contraceptive antimicrobial agent. Fertil. Steril. 81:1357-1365.
16. Matsuzaki K. 2009. Control of cell selectivity of antimicrobial peptides. Biochim. Biophys. Acta 1788:1687-1692.
17. Norberg S, O'Connor PM, Stanton C, Ross RP, Hill C, Fitzgerald GF, Cotter PD. 2012. Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change. Appl. Environ. Microbiol. 78:2353-2358.
18. Field D, Begley M, O'Connor PM, Daly KM, Hugenholtz F, Cotter PD, Hill C, Ross RP. 2012. Bioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogens. PLoS One 7:e46884. doi:10.1371/journal.pone.0046884.
19. Hancock RE, Lehrer R. 1998. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16:82-88.
20. Subramanian S, Ross NW, Mackinnon SL. 2008. Comparison of the biochemical composition of normal epidermal mucus and extruded slime of hagfish (Myxine glutinosa L.). Fish Shellfish Immunol. 25:625-632.
21. Ellis AE. 2001. Innate host defense mechanisms of fish against viruses and bacteria. Dev. Comp. Immunol. 25:827-839.
22. Subramanian S, Ross NW, MacKinnon SL. 2009. Myxinidin, a novel antimicrobial peptide from the epidermal mucus of hagfish, Myxine glutinosa L. Mar. Biotechnol. (NY) 11:748-757.
23. Galdiero S, Falanga A, Vitiello M, Browne H, Pedone C, Galdiero M. 2005. Fusogenic domains in herpes simplex virus type 1 glycoprotein H. J. Biol. Chem. 280:28632-28643.
24. Dalvit C. 1998. Efficient multiple-solvent suppression for the study of the interactions of organic solvents with biomolecules. J. Biomol. NMR 11: 437-444.
25. Wüthrich K. 1986. NMR of proteins and nucleic acids. John Wiley & Sons, New York, NY.
26. Griesinger C, Otting G, Wuethrich K, Ernst RR. 1988. Clean TOCSY for proton spin system identification in macromolecules. J. Am. Chem. Soc. 110:7870-7872.
27. Kumar A, Ernst RR, Wüthrich K. 1980. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem. Biophys. Res. Commun. 95:1-6.
28. Piantini U, Sorensen OW, Ernst RR. 1982. Multiple quantum filters for elucidating NMR coupling networks. J. Am. Chem. Soc. 104:6800-6801.
29. Bartels C, Xia TH, Billeter M, Guntert P, Wüthrich K. 1995. The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J. Biomol. NMR 6:1-10.
30. Herrmann T, Guntert P, Wüthrich K. 2002. Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J. Mol. Biol. 319:209-227.
31. Koradi R, Billeter M, Wüthrich K. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14: 51-55.
32. Doreleijers JF, Sousa da Silva AW, Krieger E, Nabuurs SB, Spronk CA, Stevens TJ, Vranken WF, Vriend G, Vuister GW. 2012. CING: an integrated residue-based structure validation program suite. J. Biomol. NMR 54:267-283.
33. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
34. Buck M. 1998. Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins. Q. Rev. Biophys. 31:297-355.
35. Wishart DS, Sykes BD, Richards FM. 1991. Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J. Mol. Biol. 222:311-333.
36. Tossi A, Sandri L, Giangaspero A. 2000. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4-30.
37. Giangaspero A, Sandri L, Tossi A. 2001. Amphipathic alpha helical antimicrobial peptides. Eur. J. Biochem. 268:5589-5600.
38. Dempsey CE, Hawrani A, Howe RA, Walsh TR. 2010. Amphipathic antimicrobial peptides -from biophysics to therapeutics? Protein Pept. Lett. 17:1334-1344.
39. Li J, Garg M, Shah D, Rajagopalan R. 2010. Solubilization of aromatic and hydrophobic moieties by arginine in aqueous solutions. J. Chem. Phys. 133:054902. doi:10.1063/1.3469790.
40. Su Y, Waring AJ, Ruchala P, Hong M. 2010. Membrane-bound dynamic structure of an arginine-rich cell-penetrating peptide, the protein transduction domain of HIV TAT, from solid-state NMR. Biochemistry 49: 6009-6020.
41. Schmidt N, Mishra A, Lai GH, Wong GC. 2010. Arginine-rich cellpenetrating peptides. FEBS Lett. 584:1806-1813.
42. Pellegrini A, von Fellenberg R. 1999. Design of synthetic bactericidal peptides derived from the bactericidal domain P(18-39) of aprotinin. Biochim. Biophys. Acta 1433:122-131.
43. Ma QQ, Dong N, Shan AS, Lv YF, Li YZ, Chen ZH, Cheng BJ, Li ZY. 2012. Biochemical property and membrane-peptide interactions of de novo antimicrobial peptides designed by helix-forming units. Amino Acids 43:2527-2536.
44. Bi X, Wang C, Ma L, Sun Y, Shang D. 2013. Investigation of the role of tryptophan residues in cationic antimicrobial peptides to determine the mechanism of antimicrobial action. J. Appl. Microbiol. 115:663-672.
45. Galdiero S, Russo L, Falanga A, Cantisani M, Vitiello M, Fattorusso R, Malgieri G, Galdiero M, Isernia C. 2012. Structure and orientation of the gH625-644 membrane interacting region of herpes simplex virus type 1 in a membrane mimetic system. Biochemistry 51:3121-3128.
46. Falanga A, Tarallo R, Vitiello G, Vitiello M, Perillo E, Cantisani M, D'Errico G, Galdiero M, Galdiero S. 2012. Biophysical characterization and membrane interaction of the two fusion loops of glycoprotein B from herpes simplex type I virus. PLoS One 7:e32186. doi:10.1371/journal.pone .0032186.
47. Falanga A, Cantisani M, Pedone C, Galdiero S. 2009. Membrane fusion and fission: enveloped viruses. Protein Pept. Lett. 16:751-759.
48. Pasupuleti M, Walse B, Svensson B, Malmsten M, Schmidtchen A. 2008. Rational design of antimicrobial C3a analogues with enhanced effects against staphylococci using an integrated structure and functionbased approach. Biochemistry 47:9057-9070.
49. Scudiero O, Galdiero S, Nigro E, Del Vecchio L, Di Noto R, Cantisani M, Colavita I, Galdiero M, Cassiman JJ, Daniele A, Pedone C, Salvatore F. 2013. Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines. Antimicrob. Agents Chemother. 57:1701-1708.
50. Scudiero O, Galdiero S, Cantisani M, Di Noto R, Vitiello M, Galdiero M, Naclerio G, Cassiman JJ, Pedone C, Castaldo G, Salvatore F. 2010. Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity. Antimicrob. Agents Chemother. 54:2312-2322.
51. Harder J, Bartels J, Christophers E, Schroder JM. 2001. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:5707-5713.